安科生物
(300009)
| 流通市值：100.06亿 | | | 总市值：136.98亿 |
| 流通股本：12.22亿 | | | 总股本：16.73亿 |
| 报告期 | 2024-09-30 | 2024-06-30 | 2024-03-31 | 2023-12-31 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 流动资产: | | | | |
| 货币资金 | 353,127,767.43 | 242,332,842.02 | 316,029,982.07 | 260,226,567.56 |
| 应收票据及应收账款 | 509,651,391.25 | 550,200,792.24 | 567,630,973.16 | 550,228,951.09 |
| 应收账款 | 509,651,391.25 | 550,200,792.24 | 567,630,973.16 | 550,228,951.09 |
| 应收款项融资 | 67,991,609.51 | 60,059,608.25 | 33,563,343.88 | 47,210,084.37 |
| 预付款项 | 46,295,840.37 | 42,201,493.73 | 36,457,687.24 | 25,677,806.19 |
| 其他应收款合计 | 14,603,999.66 | 14,599,793.51 | 14,011,628.7 | 9,002,811.55 |
| 存货 | 305,678,695.21 | 307,079,277.78 | 258,821,221.31 | 235,215,374.68 |
| 其他流动资产 | 2,577,579.52 | 1,769,375.61 | 1,034,551.94 | 2,349,649.98 |
| 流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 流动资产合计 | 2,240,715,100.01 | 2,161,578,860.88 | 2,512,247,494.21 | 2,325,483,458.75 |
| 非流动资产: | | | | |
| 债权投资 | 176,537,888.91 | 113,488,833.35 | 72,716,416.67 | 72,157,777.77 |
| 长期股权投资 | 134,931,883.12 | 129,298,240.11 | 128,450,676.95 | 167,344,181.81 |
| 其他非流动金融资产 | 150,881,340.19 | 150,881,340.19 | 162,881,340.19 | 164,881,340.19 |
| 投资性房地产 | 7,555,007.93 | 8,120,569.21 | 8,192,180.8 | 8,110,204.31 |
| 固定资产 | 737,165,608.45 | 747,319,345.5 | 737,256,322.24 | 706,153,841.12 |
| 在建工程 | 707,724,910.71 | 686,527,814.02 | 659,716,102.95 | 672,507,138.6 |
| 使用权资产 | 48,102,922.95 | 51,000,834.53 | 52,462,030.43 | 54,887,772.77 |
| 无形资产 | 421,760,189.64 | 431,279,836.03 | 440,816,067.57 | 450,361,623.07 |
| 开发支出 | 225,991,101.14 | 221,323,240.44 | 218,408,469.44 | 215,952,222.05 |
| 商誉 | 67,756,348.91 | 67,756,348.91 | 67,756,348.91 | 66,556,732.24 |
| 长期待摊费用 | 19,830,924.64 | 20,534,655.1 | 8,638,702.13 | 7,846,470.48 |
| 递延所得税资产 | 31,469,550.42 | 28,234,706.75 | 30,992,331.17 | 29,532,200.27 |
| 其他非流动资产 | 20,555,695.69 | 27,327,222.45 | 26,171,157.73 | 8,985,522.61 |
| 非流动资产平衡项目 | 0 | 0 | 0 | 0 |
| 非流动资产合计 | 2,750,263,372.7 | 2,683,092,986.59 | 2,614,458,147.18 | 2,625,277,027.29 |
| 资产平衡项目 | 0 | 0 | 0 | 0 |
| 资产总计 | 4,990,978,472.71 | 4,844,671,847.47 | 5,126,705,641.39 | 4,950,760,486.04 |
| 流动负债: | | | | |
| 短期借款 | 5,000,000 | 5,000,000 | - | - |
| 应付票据及应付账款 | 172,001,613.04 | 201,067,725.95 | 174,636,092.88 | 211,703,603.46 |
| 其中：应付票据 | 19,854,000 | 17,880,000 | 25,380,000 | 14,920,000 |
| 应付账款 | 152,147,613.04 | 183,187,725.95 | 149,256,092.88 | 196,783,603.46 |
| 合同负债 | 16,787,908.2 | 19,698,301.82 | 23,611,402.59 | 24,429,985.77 |
| 应付职工薪酬 | 67,736,665.69 | 81,348,555.25 | 153,144,083.84 | 198,343,818.21 |
| 应交税费 | 94,701,899.3 | 79,155,913.65 | 88,146,386.02 | 68,281,633.21 |
| 其他应付款合计 | 334,148,662.17 | 342,343,493.04 | 343,775,576.37 | 333,195,150.24 |
| 应付股利 | 13,178,528.5 | 13,178,528.5 | 8,689,565 | 8,689,565 |
| 一年内到期的非流动负债 | 8,125,782.01 | 9,817,181.63 | 8,055,832.05 | 8,810,791.26 |
| 其他流动负债 | 1,252,231.9 | 1,415,343.87 | 1,676,244.17 | 2,315,906.71 |
| 流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 流动负债合计 | 699,754,762.31 | 739,846,515.21 | 793,045,617.92 | 847,080,888.86 |
| 非流动负债: | | | | |
| 租赁负债 | 42,629,717.19 | 43,388,170.59 | 46,161,135.12 | 47,817,285.93 |
| 递延收益 | 107,605,124.08 | 102,151,454.87 | 112,281,272.49 | 113,522,377.24 |
| 递延所得税负债 | 8,578,614.08 | 8,980,220.6 | 9,322,384.69 | 10,008,027.71 |
| 非流动负债平衡项目 | 0 | 0 | 0 | 0 |
| 非流动负债合计 | 158,813,455.35 | 154,519,846.06 | 167,764,792.3 | 171,347,690.88 |
| 负债平衡项目 | 0 | 0 | 0 | 0 |
| 负债合计 | 858,568,217.66 | 894,366,361.27 | 960,810,410.22 | 1,018,428,579.74 |
| 所有者权益(或股东权益): | | | | |
| 实收资本(或股本) | 1,676,346,758 | 1,676,346,758 | 1,676,826,758 | 1,676,826,758 |
| 资本公积 | 546,474,289.2 | 532,625,641.52 | 531,069,186.02 | 519,816,627.91 |
| 减:库存股 | 223,906,380.61 | 223,906,380.61 | 226,215,180.61 | 226,215,180.61 |
| 盈余公积 | 369,201,720.76 | 369,201,720.76 | 369,201,720.76 | 369,201,720.76 |
| 未分配利润 | 1,569,569,737.56 | 1,395,982,467.75 | 1,615,519,552.31 | 1,397,769,620.95 |
| 归属于母公司股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 归属于母公司股东权益合计 | 3,937,686,124.91 | 3,750,250,207.42 | 3,966,402,036.48 | 3,737,399,547.01 |
| 少数股东权益 | 194,724,130.14 | 200,055,278.78 | 199,493,194.69 | 194,932,359.29 |
| 股东权益平衡项目 | 0 | 0 | 0 | 0 |
| 股东权益合计 | 4,132,410,255.05 | 3,950,305,486.2 | 4,165,895,231.17 | 3,932,331,906.3 |
| 负债和股东权益合计 | 4,990,978,472.71 | 4,844,671,847.47 | 5,126,705,641.39 | 4,950,760,486.04 |
| 公告日期 | 2024-10-25 | 2024-08-28 | 2024-04-26 | 2024-03-28 |
| 审计意见(境内) | | | | 标准无保留意见 |